Guidelines for Using Anti-COVID Drug 2-DG are Out Now by Saisruthi Sankaranarayanan on June 3, 2021 at 7:07 PM "Directions for use of 2-DG in COVID-19 patients as per DCGI approval" This "Made-in-India" drug 2-Deoxy-D-Glucose was developed by DRDO. Previously, the first batch of this drug was released on 17 May by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. Key takeaways from the guidelines ‘2-DG must be prescribed to patients who developed moderate to severe forms of SARS-CoV-2 infections and caution must be exercised while using it on people with comorbidities.’ The drug 2-DG must only be prescribed to COVID patients who have been hospitalized by moderate to severe forms of the infection.